Delivery Order SPE2DB24D3013-SPE2DB25FFQAR
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $113,093.48 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units). This firm fixed-price delivery order, issued on September 2, 2025, with an ultimate completion date of September 3, 2025, represents a non-set-aside competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Jardiance is a diabetes medication commonly used...
- The Defense Logistics Agency awarded a delivery order valued at $13,387.05 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on September 2, 2025, with an ultimate completion date of September 3, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Jardiance is a prescription medication used in diabetes management, representing one...
- The Defense Logistics Agency awarded a delivery order valued at $19,623.85 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count) on August 22, 2025, with an ultimate completion date of August 25, 2025. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Jardiance is a commonly prescribed medication for diabetes management,...
- The Defense Logistics Agency awarded a delivery order valued at $2,387.27 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units). This contract, issued on August 15, 2025, with an ultimate completion date of August 18, 2025, represents a firm fixed-price delivery order with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Jardiance is a diabetes medication commonly used within...
- The Defense Logistics Agency awarded a delivery order valued at $5,240.80 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count) on July 22, 2025, with an ultimate completion date of July 23, 2025. This firm fixed price delivery order represents a non-competitive procurement and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Jardiance is a diabetes medication commonly used in military and federal healthcare systems to...
- The Defense Logistics Agency awarded a delivery order valued at $12,196.14 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count packages) on August 8, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Jardiance is a prescription medication used in diabetes management, representing...
- The Defense Logistics Agency awarded a delivery order valued at $23,355.68 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count units) on August 25, 2025, with an ultimate completion date of August 26, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Jardiance is a prescription medication used in diabetes management,...
- The Defense Logistics Agency awarded a delivery order valued at $7,793.38 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count packages) on August 28, 2025, with completion expected by August 29, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate headquarters location in Conshohocken, Pennsylvania. Jardiance is a diabetes medication commonly used within military...
- The Defense Logistics Agency awarded a delivery order valued at $11,632.89 to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Jardiance 10 mg tablets (90-count packages). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of July 23, 2025, with performance at the vendor's facility in Conshohocken, Pennsylvania. Jardiance is a diabetes medication commonly prescribed for type 2 diabetes management, reflecting the critical pharmaceutical supply needs...
- The Defense Logistics Agency awarded a delivery order valued at $39,850.61 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on August 12, 2025, with completion targeted for August 13, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Jardiance is a diabetes medication commonly used within military and...
- SPE2DB24D3013Indefinite Delivery Contract
- SPE2DB24D3013-SPE2DB25FFQARDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,017.88 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count) on September 2, 2025, with an ultimate completion date of September 3, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. Jardiance is a prescription diabetes medication commonly used in military and federal healthcare systems to manage type 2 diabetes. This delivery order is a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement and supplies a broad range of medications, vaccines, and medical devices to support military healthcare programs worldwide. The company's extensive portfolio of DLA contracts demonstrates its capability to meet varied federal pharmaceutical supply requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.0k | 9/2/25 |